Effects of Arabinoxylan-Oligosaccharides Compared to Other Prebiotics in Healthy Subjects

C

Catholic University (KU) of Leuven

Status and phase

Completed
Phase 4

Conditions

Healthy

Treatments

Dietary Supplement: AXOS
Dietary Supplement: FOS-IN

Study type

Interventional

Funder types

Other

Identifiers

NCT00853034
AXOS 001

Details and patient eligibility

About

The purpose of the study is to evaluate the effects of arabinoxylan-oligosaccharides (AXOS) on the colonic metabolism and microbial composition, and to compare these effects with the reference prebiotic fructo-oligosaccharide enriched inulin.

Enrollment

20 patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy
  • 18-45 years
  • regular eating pattern

Exclusion criteria

  • gastrointestinal complaints
  • antibiotic intake
  • medication influencing gut transit or microbiota
  • abdominal surgery
  • pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

20 participants in 2 patient groups

FOS-IN
Active Comparator group
Description:
prebiotic fructo-oligosaccharide enriched inulin
Treatment:
Dietary Supplement: FOS-IN
AXOS
Experimental group
Description:
arabinoxylan-oligosaccharides (AXOS)
Treatment:
Dietary Supplement: AXOS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems